General
Preferred name
NITRIC OXIDE
Synonyms
Nitric oxide trimer ()
Genosyl ()
Inomax ()
Amidogen, oxo- ()
Inovent ()
Nitrosyl radical ()
OHM-11771 ()
Nitrogen oxide (no) ()
P&D ID
PD010028
CAS
10102-43-9
Tags
drug
inorganic
Approved by
EMA
FDA
First approval
1999
Drug indication
Tinea pedis
Respiratory failure
Congestive heart failure
Solid tumour/cancer
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCPRITION
A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
203
Molecular Weight
30.0
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
0
Aromatic Ring Count
0
cLogP
-0.45
TPSA
39.37
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
0.0
QED
0.36
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Therapeutic Class
Bronchodilator Agents
Source data

